Veracyte | VCYT - Gross Profit On Sales


Veracyte reported $108.55M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Agenus USD 33.74M 468K Mar/2026
Agilent USD 1.04B 52M Jun/2026
Anika Therapeutics USD 19.18M 3.6M Dec/2025
Arrowhead Research USD 75.25M 1.52M Jun/2026
Bruker USD 416M 36.2M Jun/2026
Heron Therapeutics USD 29.47M 3.17M Dec/2025
Illumina USD 770M 49M Jun/2026
Intrexon USD -297K 167K Jun/2024
Karyopharm Therapeutics USD 33.72M 1.13M Mar/2026
Laboratory Of America USD 1.11B 98.2M Jun/2026
Ligand Pharmaceuticals USD 100.41M 51.96M Jun/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Roche Holding CHF 22.69B 600M Jun/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Siemens EUR 7.68B 51M Mar/2026
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Veracyte USD 108.55M 7.39M Jun/2026
Waters USD 490M 52M Jun/2026